Addison-Davis receives funding of USD0.75m for its "Parents' Tool" drug test programme
By M2 Last Update: 9/26/2005 8:52:49 AM Data provided by
Sep 26, 2005 (M2 EQUITYBITES via COMTEX) -- Addison-Davis Diagnostics Inc (OTC BB:ADDI.OB), a diagnostic test company, announced on Friday (23 September) that it has received funding of USD750,000.
The company intends to use the proceeds from the funding to further its over-the-counter sales programme for the "Parents' Tool" Drug Test Program and its Drug Stop product with the goal of a national distribution campaign in the US.
The company also plans to implement the "Parents' Tool" interactive web portal which will allow parents to interact directly and find information to help keep children drug-free.
Addison-Davis said that the goal is to execute its business plan and produce results for its shareholders.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.